Yabao Pharmaceutical Group Co., Ltd

Informe acción SHSE:600351

Capitalización de mercado: CN¥4.4b

Yabao Pharmaceutical Group Dirección

Dirección controles de criterios 0/4

Actualmente no disponemos de información suficiente sobre el CEO.

Información clave

Wei Ren

Chief Executive Officer (CEO)

CN¥2.1m

Compensación total

Porcentaje del salario del CEOn/a
Permanencia del CEOno data
Participación del CEO0.1%
Permanencia media de la direcciónsin datos
Promedio de permanencia en la Junta Directivasin datos

Actualizaciones recientes de la dirección

Recent updates

Yabao Pharmaceutical Group (SHSE:600351) Seems To Use Debt Rather Sparingly

Oct 01
Yabao Pharmaceutical Group (SHSE:600351) Seems To Use Debt Rather Sparingly

Yabao Pharmaceutical Group's (SHSE:600351) Strong Earnings Are Of Good Quality

May 02
Yabao Pharmaceutical Group's (SHSE:600351) Strong Earnings Are Of Good Quality

CEO

Wei Ren (38 yo)

no data

Permanencia

CN¥2,073,700

Compensación

Mr. Wei Ren serves as General Manager and Vice Chairman at Yabao Pharmaceutical Group Co., Ltd and served as its Deputy General Manager. Mr. Wei served as General manager in Beijing Yabao Investment Manage...